Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shang, Desi ^a   Li, Chunquan ^a   Yao, Qianlan ^a   Yang, Haixiu ^a   Xu, Yanjun ^a   Han, Junwei ^a   Li, Jing ^a   Su, Fei ^a   Zhang, Yunpeng ^a   Zhang, Chunlong ^a   Li, Dongguo ^b   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MINERALOCORTICOID;

ADDISON DISEASE; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOSYNTHESIS; DATA BASE; HUMAN; IMMUNOPATHOLOGY; METABOLIC DISORDER; METABOLITE; METABOLOMICS; METHODOLOGY; PHENOTYPE; PRIORITIZATION OF CANDIDATE METABOLITES USING FUNCTIONAL RELATIONSHIPS; PROBABILITY; PROSTATE CANCER; PROTEIN METABOLISM; RECEIVER OPERATING CHARACTERISTIC; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; VALIDATION PROCESS; ALGORITHM; COMPUTER PROGRAM; COMPUTER SIMULATION; MALE; METABOLISM; PROSTATE TUMOR; PROTEIN ANALYSIS;

ALGORITHMS; ALZHEIMER DISEASE; COMPUTER SIMULATION; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; PROSTATIC NEOPLASMS; PROTEIN INTERACTION MAPPING; SOFTWARE;

EID: 84929515668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104934     Document Type: Article

References (56)

1. Nicholson K, Lindon C (2008) Systems biology: Metabonomics. Nature 455: 1054-1056
2. Nicholson K, Connelly J, Lindon C, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-161 (Pubitemid 41646523)
3. Fiehn O (2002) Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171
4. Hollywood K, Brison R, Goodacre R (2006) Metabolomics: current technologies and future trends. Proteomics 6: 4716-4723 (Pubitemid 44375842)
5. Kell B (2004) Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol 7: 296-307
6. Wilson D, Plumb R, Granger J, Major H, Williams R, et al. (2005) HPLC-MS-based methods for the study of metabonomics. J Chromatogr B Analyt Technol Biomed Life Sci 817: 67-76 (Pubitemid 40174790)
7. Mishur J, Rea L (2011) Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31: 70-95
8. Lee S, Park J, Kay A, Christakis A, Oltvai N, et al. (2008) The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A 105: 9880-9885
9. Cottret L, Wildridge D, Vinson F, Barrett P, Charles H, et al. (2010) MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks. Nucleic Acids Res 38: W132-137
10. Draghici S, Khatri P, Tarca A L, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545 (Pubitemid 47529438)
11. Jamshidi N, Palsson B O (2006) Systems biology of SNPs. Mol Syst Biol 2: 38
12. Oti M, Brunner H G (2007) The modular nature of genetic diseases. Clin Genet 71: 1-11 (Pubitemid 44921616)
13. Li X, Li C, Shang D, Li J, Han J, et al. (2011) The Implications of Relationships between Human Diseases and Metabolic Subpathways. PLoS One 6: e21131
14. Antonov V, Dietmann S, Mewes W (2008) KEGG spider: interpretation of genomics data in the context of the global gene metabolic network. Genome Biol 9: R179
15. Guimera R, Nunes A (2005) Functional cartography of complex metabolic networks. Nature 433: 895-900 (Pubitemid 40314902)
16. Hao T, Ma W, Zhao M, Goryanin I (2010) Compartmentalization of the Edinburgh Human Metabolic Network. BMC Bioinformatics 11: 393
17. Ma H, Sorokin A, Mazein A, Selkov A, Selkov E, et al. (2007) The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 3: 135
18. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita K F, Itoh M, et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-357
19. Wishart S, Knox C, Guo C, Eisner R, Young N, et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-610
20. Kohler S, Bauer S, Horn D, Robinson N (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82: 949-958
21. Wishart S, Jewison T, Guo C, Wilson M, Knox C, et al. (2013) HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res 41: D801-807
22. Joseloff E, Sha W, Bell C, Wetmore R, Lawton A, et al. (2013) Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis. Pediatr Pulmonol
23. Krysiak R, Okopien B (2012) [Adrenal insufficiency]. Wiad Lek 65: 108-123
24. Mishur J, Rea L (2012) Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31: 70-95
25. Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol Scand Suppl 185: 50-57 (Pubitemid 44015225)
26. Lukiw J, Cui G, Marcheselli L, Bodker M, Botkjaer A, et al. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115: 2774-2783 (Pubitemid 41434404)
27. Hook G, Hook V, Kindy M (2011) The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity. J Alzheimers Dis 26: 387-408
28. Hua X, Lei M, Ding J, Han Q, Hu G et al. (2008) Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes. Exp Neurol 210: 709-718
29. Hua X, Lei M, Zhang Y, Ding J, Han Q, et al. (2007) Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease. Life Sci 80: 1897-1905 (Pubitemid 46560732)
30. Kitzmueller E, Greber S, Fountoulakis M, Lubec G (2001) Carbohydrate handling enzymes in fetal Down syndrome brain. J Neural Transm Suppl, 203- 210
31. Lee I, Lee H, Lee C, Lee M, Lee H (2008) Calcium and neostigmine antagonize gentamicin, but augment clindamycin-induced tetanic fade in rat phrenic nerve-hemidiaphragm preparations. J Anesth 22: 385-390
32. Naj C, Beecham W, Martin R, Gallins J, Powell H, et al. (2010) Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet 6
33. Picklo J, Olson J, Markesbery R, Montine J (2001) Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J Neuropathol Exp Neurol 60: 686-695
34. Wood L, Khan A, Moskal R (2007) The concept of "aldehyde load" in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line. Brain Res 1145: 150-156
35. Michel M, Gsell W, Kasbauer L, Tatschner T, Sheldrick J, et al. (2010) Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study. J Alzheimers Dis 19: 1295-1301
36. Sherif M, Ahmed S (1995) Basic aspects of GABA-transaminase in neuropsychiatric disorders. Clin Biochem 28: 145-154
37. Sreekumar A, Poisson M, Rajendiran M, Khan P, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914
38. Fu M, Lin H, Liu X, Fang W, Meadows G (2010) Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism. J Cell Physiol 224: 491-500
39. Giovannucci E, Rimm B, Wolk A, Ascherio A, Stampfer J, et al. (1998) Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 58: 442-447 (Pubitemid 28087404)
40. Gu M, Roy S, Raina K, Agarwal C, Agarwal R (2009) Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target. Cancer Res 69: 9465-9472
41. Hakim S, Bertucci C, Conduit S E, Vuong L, Mitchell A (2012) Inositol polyphosphate phosphatases in human disease. Curr Top Microbiol Immunol 362: 247-314
42. Hassan S, Abdel Rahman E (2013) Synthesis and biological evaluation of some substituted-2-N-(5-chloro-2-methoxy-4-methylphenylsulphonyl) glutamic acid derivatives against prostate cancer cell line PC3. Chem Pharm Bull (Tokyo) 61: 212-221
43. Koochekpour S (2013) Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. Asian J Androl 15: 212-213
44. Koochekpour S, Majumdar S, Azabdaftari G, Attwood K, Scioneaux R, et al. (2012) Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clin Cancer Res 18: 5888-5901
45. Levin S, Albers J, Butler N, Spielman D, Peehl M, et al. (2009) Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate. Magn Reson Med 62: 1091-1098
46. Liu W, Le A, Hancock C, Lane N, Dang V, et al. (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A 109: 8983-8988
47. Serkova J, Gamito J, Jones H, O'Donnell C, Brown L, et al. (2008) The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate 68: 620-628 (Pubitemid 351614640)
48. Singh G, Lakkis L, Laucirica R, Epner E (1999) Regulation of prostate cancer cell division by glucose. J Cell Physiol 180: 431-438 (Pubitemid 29334844)
49. Singh P, Agarwal C, Agarwal R (2003) Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Carcinogenesis 24: 555-563 (Pubitemid 36432653)
50. Stenman K, Stattin P, Stenlund H, Riklund K, Grobner G, et al. (2011) H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples. Biomark Insights 6: 39-47
51. Szabo S, Lippe T (1989) Adrenal gland: chemically induced structural and functional changes in the cortex. Toxicol Pathol 17: 317-329 (Pubitemid 19218941)
52. Szabo Z, Hamalainen J, Loikkanen I, Moilanen M, Hirvikoski P, et al. (2010) Sorbitol dehydrogenase expression is regulated by androgens in the human prostate. Oncol Rep 23: 1233-1239
53. Taylor S, Pal M, Yu J, Laxman B, Kalyana-Sundaram S, et al. (2008) Humoral response profiling reveals pathways to prostate cancer progression. Mol Cell Proteomics 7, 600-611 (Pubitemid 351472469)
54. Teicher A, Linehan M, Helman J (2012) Targeting cancer metabolism. Clin Cancer Res 18: 5537-5545
55. Bianchini A, Loiarro M, Bielli P, Busa R, Paronetto P, et al. (2008) Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells. Carcinogenesis 29: 2279-2288
56. Trock J (2011) Application of metabolomics to prostate cancer. Urol Oncol 29: 572-581